Arab Today, arab today alexion to buy synageva biopharma in 84bn deal
Last Updated : GMT 18:22:38
Arab Today, arab today
Arab Today, arab today

Alexion to buy Synageva BioPharma in $8.4bn deal

Arab Today, arab today

Arab Today, arab today Alexion to buy Synageva BioPharma in $8.4bn deal

Alexion Pharmaceuticals
New York - AFP

Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion's business in treatments for rare diseases, the US companies announced Wednesday.

Alexion's takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock. That represents a 140 percent premium to Synageva's closing share price Tuesday at $95.87.

"Synageva is an ideal strategic and operational fit for Alexion that aligns with what we know well and do well -- providing life-transforming therapies to an increasing number of patients with devastating and rare diseases," said David Hallal, Alexion chief executive, in a statement.

The Alexion acquisition will add Synageva's Kanuma treatment for patients suffering from Lysosomal Acid Lipase Deficiency, a rare and life-threatening disease caused by genetic mutations that lead to a buildup of fatty material in the liver and other tissues.

Kanuma is expected to be launched on the global market this year, Hallal said. Kanuma is under a priority review for approval by US and European health authorities.

Alexion's acquisition of Synageva's treatment pipeline "creates the most robust rare disease pipeline in biotech," the companies said.

Alexion projected the combined company would achieve annual cost savings that reach at least $150 million in 2017. The transaction is expected to close in mid-2015.

Shares in Synageva shot up 112.8 percent to $204.04 in opening Nasdaq trade, while Alexion dropped 9.6 percent to $152.32.

 

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

Arab Today, arab today alexion to buy synageva biopharma in 84bn deal Arab Today, arab today alexion to buy synageva biopharma in 84bn deal

 



Arab Today, arab today

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

Arab Today, arab today alexion to buy synageva biopharma in 84bn deal Arab Today, arab today alexion to buy synageva biopharma in 84bn deal

 



Arab Today, arab today France defies terrorism through tourism

GMT 15:18 2017 Saturday ,20 May

France defies terrorism through tourism
Arab Today, arab today Mai Al-Jeddawi presents décor ideas for Ramadan
Arab Today, arab today Sally Shaheen considers hosting a political show
View News in Arabic - Business: أخبار الشركات
Arab Today, arab today
Arab Today, arab today
Arab Today, arab today
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube
arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday